New uses for older antibiotics: The 'rediscovery' of four beneficial and cost-effective antimicrobials

Postgraduate Medicine

Volumn 101, Issue 4, 1997, Pages

  Cunha, Burke A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; COTRIMOXAZOLE; DOXYCYCLINE; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; COLITIS; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG INDICATION; DRUG TISSUE LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALARIA FALCIPARUM; ORAL DRUG ADMINISTRATION; REVIEW;

EID: 0031002698     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1997.04.197     Document Type: Review

References (19)

1. Karlsson M, Hammers-Berggren S, Lindquist L, et al. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 1994;44(7):1203-7
2. Cunha BA. Clinical uses of the tetracyclines. In: Blackwood RK, Hlavka JJ, Boothe JH, eds. The tetracyclines. New York: Springer-Verlag, 1985:393
3. Cunha BA, Comer JB, Jonas M. The tetracyclines. Med Clin North Am 1982;66(1):293-302
4. Cunha BA, Jonas M. Legionnaires' disease treated with doxycycline. (Letter) Lancet 1981;1(8229):1107
5. Klein NC, Cunha BA. Tetracyclines. Med Clin North Am 1995;79(4):789-801
6. Shea KW, Cunha BA, Ueno Y, et al. Doxycycline activity against Streptococcus pneumonias. (Letter) Chest 1995;108(6):1775-6
7. Freeman CD, Nightingale CH, Quintiliani R. Minocycline: old and new therapeutic uses. Int J Antimicrob Agents 1994;4:325-35
8. Minuth JN, Holmes TM, Musher DM. Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and resistant staphylococci. Antimicrob Agents Chemother 1974;6(4):411-4
9. Nicolau DP, Freeman CD, Nightingale CH, et al. Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1994;38(7):1515-8
10. Dudley MN, Levitz RE, Quintiliani R, et al. Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges. Antimicrob Agents Chemother 1984;26(6):811-4
11. Haataja M, Hanninen P, Platin LH, et al. Trimethoprim or cotrimoxazole in pneumonia. Curr Ther Res Clin Exp 1985;37(2):191-6
12. Spitzer PG, Hammer SM, Karchmer AW. Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature. Rev Infect Dis 1986;8(3):427-30
13. Schiraldi O, Sforza E, Piaia F. Effect of a new sulfa-trimethoprim combination (trimethoprim-sulfamethopyrazine) in typhoid fever: a double-blind study on 72 adult patients. Chemotherapy 1985;31(1):68-75
14. Chin TW, Vandenbroucke A, Fong IW. Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients. Antimicrob Agents Chemother 1995;39(1):28-33
15. Gorbach SL. Antibiotic treatment of anaerobic infections. Clin Infect Dis 1994;18(Suppl 4):305-10S
16. Mathisen GE, Finegold SM. Metronidazole and other nitroimidazoles. In: Gorbach SL, Sherwood L, Bartlett JG, et al, eds. Infectious diseases. Philadelphia: Saunders, 1992:260
17. Saginur R, Hawley CR, Bartlett JG. Colitis associated with metronidazole therapy. J Infect Dis 1980;141(6):772-4
18. Teasley DG, Gerding DN, Olson MM, et al. Prospective randomised trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhoea and colitis. Lancet 1983;2(8358):1043-6
19. Falagas ME, Gorbach SL. Clindamycin and metronidazole. Med Clin North Am 1995;79(4):845-67